How much does bosutinib cost? What is its market pricing and fees?

Bosutinib is a targeted drug used to treat chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML). It mainly prevents cancer cell proliferation by inhibiting BCR-ABL kinase activity. Although bosutinib has significant effects in treating these diseases, the drug is currently not approved in the Chinese market, so patients usually need to purchase it from abroad.

The original research version of bosutinib is relatively expensive, especially in the European market. A box of 500mg*28 tablets of the European version of the original drug is priced at more than 30,000 yuan. This price may constitute a large financial burden for most patients, especially in the case of long-term treatment. Therefore, patients often need to consider affordability when choosing this drug and may need to rely on insurance or other funding programs to cover part of the cost.

In order to reduce treatment costs, generic versions have become the choice of some patients. The price of the bosutinib generic drug produced by India's Mylan (Mylan) is relatively cheap. Each box of 500mg*28 tablets is priced at about more than 1,000 yuan. Indian generic drugs are low-cost and internationally recognized for their quality, making them an economical choice for many patients. The use of generic drugs can significantly reduce the cost of treatment, especially for patients with chronic myelogenous leukemia who require long-term medication.

Although the price difference between original drugs and generic drugs is large, their drug ingredients and therapeutic effects are basically the same. Generic drugs undergo strict quality control and can provide similar therapeutic effects to the brand-name drugs. Therefore, in many cases, generic drugs are an ideal choice for patients to control the cost of treatment.

Overall, the price difference of bosutinib is mainly reflected between the original drug and generic drugs. Patients should choose a suitable drug version based on their own financial situation and treatment needs, and conduct treatment under the guidance of a doctor.

Reference materials:https://go.drugbank.com/drugs/DB06616